Source:http://linkedlifedata.com/resource/pubmed/id/19060920
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-2-12
|
pubmed:abstractText |
The c-Jun NH2-terminal kinase (JNK) pathway represents one subgroup of MAP kinases that are activated primarily by cytokines and exposure to environmental stress. Autophagy is a protein-degradation system characterized by the formation of double-membrane vacuoles termed autophagosomes. Autophagy-related gene beclin 1 plays a key role in autophagosome formation. However, the relationships between activation of JNK pathway, autophagy induction and Beclin 1 expression remain elusive. In this study, we used human cancer cell lines CNE2 and Hep3B to investigate the role of JNK-mediated Beclin 1 expression in ceramide-induced autophagic cell death. Ceramide-treated cells exhibited the characteristics of autophagy (that is, acidic vesicular organelle formation and the LC3-II generation). JNK was activated in these two cell lines exposed to ceramide and the phosphorylation of c-Jun also increased. In the meantime, we found that ceramide upregulated Beclin 1 expression in cancer cells. The upregulation of Beclin 1 expression could be blocked by SP600125 (a specific inhibitor of JNK) or a small interfering RNA (siRNA) directed against JNK1/2 or c-Jun. Chromatin immunoprecipitation and luciferase reporter analysis revealed that c-Jun was involved in the regulation of beclin 1 transcription in response to ceramide treatment. In addition, inhibition of JNK activity by SP600125 could inhibit autophagy induction by ceramide. Furthermore, Beclin 1 knockdown by siRNA also inhibited ceramide-mediated autophagic cell death. JNK-mediated Beclin 1 expression was also observed in topotecan-induced autophagy. These data suggest that activation of JNK pathway can mediate Beclin 1 expression, which plays a key role in autophagic cell death in cancer cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anthracenes,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Apoptosis Regulatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/BECN1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Ceramides,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/JNK Mitogen-Activated Protein...,
http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 4,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/anthra(1,9-cd)pyrazol-6(2H)-one
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1476-5594
|
pubmed:author |
pubmed-author:DengRR,
pubmed-author:DowJJ,
pubmed-author:FengG-KGK,
pubmed-author:HWAE CEC,
pubmed-author:HuangW-LWL,
pubmed-author:MUNN VNV,
pubmed-author:ShenYY,
pubmed-author:TangJJ,
pubmed-author:WITS JSJ,
pubmed-author:WangL-LLL,
pubmed-author:WangYY,
pubmed-author:YunY KYK,
pubmed-author:ZengY-XYX
|
pubmed:issnType |
Electronic
|
pubmed:day |
12
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
886-98
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:19060920-Anthracenes,
pubmed-meshheading:19060920-Antineoplastic Agents,
pubmed-meshheading:19060920-Apoptosis Regulatory Proteins,
pubmed-meshheading:19060920-Autophagy,
pubmed-meshheading:19060920-Caspase 3,
pubmed-meshheading:19060920-Cell Line, Tumor,
pubmed-meshheading:19060920-Ceramides,
pubmed-meshheading:19060920-Enzyme Inhibitors,
pubmed-meshheading:19060920-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19060920-Humans,
pubmed-meshheading:19060920-JNK Mitogen-Activated Protein Kinases,
pubmed-meshheading:19060920-MAP Kinase Kinase 4,
pubmed-meshheading:19060920-Membrane Proteins,
pubmed-meshheading:19060920-Phagosomes,
pubmed-meshheading:19060920-Phosphorylation,
pubmed-meshheading:19060920-RNA, Small Interfering
|
pubmed:year |
2009
|
pubmed:articleTitle |
The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.
|
pubmed:affiliation |
State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, Guangzhou, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|